Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial

Affiliations

• ¹ Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.
• ² Oxford University Clinical research Unit - Nepal, Patan Hospital, Kathmandu, Nepal.
• ³ Center for Vaccine Development and Global Health, University of Maryland, Baltimore, MD, USA.
• ⁴ Paediatric Research Unit, Patan Hospital, Kathmandu, Nepal.